Results 41 to 50 of about 14,994 (170)

Congenital cutaneous multifocal kaposiform hemangioendothelioma

open access: yes, 1999
Kaposiform hemangioendothelioma is a rare vascular neoplasm in children often associated with Kasabach-Merritt syndrome. The tumor usually presents in retroperitoneal location and is rarely present at birth.
R. Gianotti, C. Gelmetti, E. Alessi
core   +1 more source

Spindle cell hemangioendothelioma presenting as fracture femur – A rare case presentation

open access: yesAnnals of Oncology Research and Therapy, 2022
Hemangioendothelioma (HE) is a vascular malignancy which shows a borderline biological behavior. Spindle cell HE (SCHE) is a type of hemangioendothelioma, first described by Weiss and Enzinger in 1986. We present a case of 58-year-old male, who presented
Kafil Akhtar   +3 more
doaj   +1 more source

Endoscopic Suture Ligation and Sclerotherapy for Pharyngolaryngeal Venous Malformation

open access: yesThe Laryngoscope, Volume 136, Issue 8, Page 3477-3486, August 2026.
This study evaluated suture ligation combined with sclerotherapy in 53 patients with pharyngolaryngeal venous malformations. A single procedure achieved complete resolution in 79.25% of cases, with no serious complications or need for prophylactic tracheostomy.
Jiajun Tian   +5 more
wiley   +1 more source

Surgical treatment of a huge kaposiform hemangioendothelioma in the chest wall: A case study

open access: yesSAGE Open Medical Case Reports, 2016
Kaposiform hemangioendothelioma, a rare vascular pediatric tumor often associated with Kasabach–Merritt phenomenon, is characterized by severe thrombocytopenia and consumptive coagulopathy.
Xiaonan Guo, Yubin Gong, Changxian Dong
doaj   +1 more source

Epithelioid hemangioendothelioma of spine: A case report with review of literatures

open access: yesRadiology Case Reports, 2020
Primary epithelioid hemangioendothelioma of the spine is the extremely rare malignant vascular neoplasm with an unpredictable outcome. A case of epithelioid hemangioendothelioma with multiple lytic lesions of thoracolumbar spine and other bones in a 29 ...
Ping-Kang Chen, MS   +4 more
doaj   +1 more source

Management and outcomes of advanced hemangioendothelioma at a medical oncology clinic in an Indian tertiary care center

open access: yesFuture Science OA, 2022
Aim: Hemangioendotheliomas (HEs) are malignant vascular tumors with sparse descriptions in literature owing to their rarity. Study design: Ours is a retrospective study among patients of advanced HEs registered between September 2015 and April 2021 ...
Ghazal Tansir   +8 more
doaj   +1 more source

RAS Inhibitor RMC‐7977 Blocks Vascular Overgrowth of NRASQ61R Mutant Endothelial Cells

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 15, August 2026.
ABSTRACT RAS mutations occur in patients with several types of vascular anomalies, but effective treatments remain limited. To address this need, we evaluated the RAS (ON) multi‐selective inhibitor RMC‐7977 in human endothelial cells (ECs) expressing the NRASQ61R mutation found in kaposiform lymphangiomatosis (KLA).
Sara Alharbi   +6 more
wiley   +1 more source

Epithelioid Hemangioendothelioma of the Distal Radius: A Case Report [PDF]

open access: yes, 2007
Epithelioid hemangioendothelioma is a rare vascular tumor with cytologic behavior between angiosarcoma and hemangioma. We present the case of a 58-year-old male with primary epithelioid hemangioendothelioma of the distal radius measuring 6.2 × 5 cm with ...
Craft, Randall O.   +4 more
core   +1 more source

Hemangioendothelioma of the lung

open access: yes, 1979
Bursa Üniversitesi Tıp Fakültesi Göğüs Hastalıkları ve Tüberküloz Kürsüsü'nde yatan bir olguda Malign Hemangioendothelioma saptanmış ve çok nadir görüldüğünden yayınlanmıştır.A case of malignant hemangioendothelioma was treated in the clinic of Pulmonary

core   +1 more source

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

open access: yesPediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy